From maternal blood, the PrenaTest® can detect changes in the genetic material of the unborn child, known as chromosomal disorders. It is a safe test that is harmless to the child. The PrenaTest® determines with high accuracy, whether the examined chromosomal disorder is present or not.
The PrenaTest® is a safe and reliable non-invasive prenatal test (NIPT) for the determination of fetal trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), maldistributions of sex chromosomes X and Y (Klinefelter, Turner, triple X and XYY syndrome) and the 22q11.2 microdeletion (DiGeorge syndrome). The PrenaTest® can also be performed in the case of a twin pregnancy, following fertility treatment, for example following IVF or ICSI, as well as after egg donation. If desired, you can also learn whether you are expecting a girl or a boy.
28.04.2017: LifeCodexx and Charité to form research alliance... more
09.03.2017: New technology for a cost efficient, fast NIPT… more
06.03.2017: Validation study and pilot projects in several European countries demonstrated highest test accuracies …more
